Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327 (22 November), doi:10.1136/bmj.327.7425.0-f
A comprehensive classification of adverse drug reaction should take into account dose response, time course of the reaction, and susceptibility of the patient (DoTs). Aronson and Ferner (p 1222) argue that the current drug classification defined only by properties of the drug gives only a limited amount of insight into drug reactions. Their proposed classification would provide more details on adverse reactions and improve drug development and patient care.
|
|
Credit: SPL
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?